Phenazopyridine is not recommended while breastfeeding. Its safety has not been established in nursing infants, and the LactMed database, the primary U.S. reference for drug safety during lactation, advises against its use due to the risk of serious blood-related side effects in infants.
Why Phenazopyridine Is a Concern
Phenazopyridine is a urinary tract analgesic, the medication that turns your urine orange and takes the edge off the burning pain of a UTI. It is not an antibiotic and does not treat the infection itself. It is not known whether phenazopyridine passes into breast milk, but the drug carries specific risks that make it a poor choice for nursing mothers.
The core concern is that phenazopyridine can cause methemoglobinemia, a condition where red blood cells lose their ability to carry oxygen effectively. It can also trigger hemolytic anemia, where red blood cells break down faster than the body can replace them. Newborns are especially vulnerable to both of these because their blood chemistry is less equipped to handle oxidative stress than an older child’s or adult’s.
Which Infants Face the Highest Risk
Two groups of breastfed babies are at particular risk. Infants under one month of age have immature enzyme systems that make them far more susceptible to methemoglobinemia. And babies with G6PD deficiency, a relatively common inherited enzyme condition, are prone to severe hemolytic anemia when exposed to oxidizing substances. G6PD deficiency affects roughly 400 million people worldwide and is more prevalent in families of African, Mediterranean, Middle Eastern, and Southeast Asian descent. Many parents do not know their infant has it until an exposure triggers a crisis.
Because the drug’s transfer into breast milk hasn’t been measured, there is no established “safe” dose for a nursing infant. The lack of data itself is part of the problem: without knowing how much reaches the baby, the potential severity of these side effects makes avoidance the standard recommendation.
Signs of Trouble in an Infant
If you’ve already taken phenazopyridine while breastfeeding, watch your baby for specific warning signs. Methemoglobinemia can cause a blue or gray tint to the lips, fingernails, or skin, along with unusual fatigue, difficulty breathing, or severe irritability. Hemolytic anemia may show up as sudden jaundice (yellowing of the skin or whites of the eyes), pale skin, dark urine, or extreme lethargy. These symptoms would need immediate medical attention.
Safer Options for UTI Pain While Nursing
The burning, urgency, and pressure of a UTI are miserable, and you still have good options for relief. Ibuprofen is considered highly compatible with breastfeeding. Studies show it transfers poorly into breast milk and has an excellent safety profile in infants. It reduces both pain and inflammation, making it effective for the discomfort that comes with a urinary tract infection. Acetaminophen is another safe choice during lactation and can be alternated with ibuprofen if one alone isn’t enough.
Beyond pain relief, treating the underlying infection is the fastest path to feeling better. Most UTI symptoms improve significantly within 24 to 48 hours of starting an appropriate antibiotic, and several commonly prescribed antibiotics are compatible with breastfeeding. Drinking plenty of water and urinating frequently can also help flush bacteria and reduce irritation in the meantime.
Phenazopyridine is typically only meant for short-term use (two days at most when taken alongside an antibiotic), so the window where you’d want it is brief. For most breastfeeding mothers, the combination of a safe pain reliever and a properly chosen antibiotic will cover that window without the added risk.